4.2 Article

The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection*

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties

Matthew G. Frank et al.

Summary: SARS-CoV-2 infection can lead to neuroinflammation and neurological symptoms, with the structural protein S1 potentially inducing these processes independently of viral infection. Experimental findings show that S1 causes various physiological and behavioral changes in rats and microglial cells in vitro, as well as alterations in neuroimmune gene and protein expression, suggesting a role in neuroinflammatory processes via receptor engagement.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Immunology

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Alana F. Ogata et al.

Summary: The study found that most participants showed detectable levels of SARS-CoV-2 protein as early as day 1 after receiving the mRNA-1273 vaccine, and the clearance of detectable SARS-CoV-2 protein correlated with the production of immunoglobulin G (IgG) and immunoglobulin A (IgA).

CLINICAL INFECTIOUS DISEASES (2022)

Article Pathology

The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder

Gerard J. Nuovo et al.

Summary: The study found that SARS-CoV2 RNA and nucleocapsid protein can be detected in the liver of fatal COVID-19 cases, with a significant amount of SARS-CoV-2 spike protein. Patients with pre-existing alcohol use disorder are at higher risk of severe liver disease with COVID-19 infection.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

News Item Medicine, General & Internal

The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks

Jennifer Abbasi

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Clinical Neurology

Neurovascular injury with complement activation and inflammation in COVID-19

Myoung Hwa Lee et al.

Summary: This autopsy study reveals the underlying mechanisms of brain microvascular pathology in patients with COVID-19, including vascular leakage, platelet aggregation, neuroinflammation, and neuronal injury, which are likely initiated by antibody-mediated cytotoxicity against brain endothelial cells.
Article Pathology

Histologic, viral, and molecular correlates of heart disease in fatal COVID-19

Louisa Mezache et al.

Summary: Cardiac manifestations are common in severe COVID-19. This study compared the histologic, viral, and molecular findings in cardiac tissue in fatal COVID-19 and controls. The study found higher ACE2 expression in the heart tissues of cases and controls with obesity or type II diabetes. Unique pathological characteristics, such as endothelial cell swelling, perivascular edema, and microvascular thrombi, were observed in the cases. Spike protein of SARS-CoV-2 was detected in abundance, indicating its potential association with myocarditis and abnormal localization of intercalated disc proteins.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

Review Endocrinology & Metabolism

Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)

Yue Zhou et al.

Summary: The Covid-19 outbreak has evolved into a global health crisis, with the increasing prevalence of obesity and diabetes exacerbating the risks of infectious diseases. This study provides a synthesis of recent advances in understanding the relationships between obesity, diabetes, and Covid-19, offering special treatment guidance for these at-risk populations.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)

Article Pathology

Severe COVID-19: A multifaceted viral vasculopathy syndrome

Cynthia M. Magro et al.

Summary: This study reveals two distinct mechanisms of severe COVID-19 infection: microangiopathy of pulmonary capillaries with high viral load leading to endothelial cell death, and pseudovirions docking on ACE2+ endothelial cells in skin/subcutaneous fat and brain triggering complement pathway/coagulation cascade and cytokine storm. The data suggests potential therapies targeting circulating viral proteins or endothelial-induced response for a favorable outcome.

ANNALS OF DIAGNOSTIC PATHOLOGY (2021)

Article Neurosciences

Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets

Md. Sahab Uddin et al.

Summary: Alzheimer's disease is a common form of dementia in elderly people, with approved medications including ChEIs and NMDAR antagonists. Single-target therapies have shown to be unsuccessful in treating the multifactorial symptoms or disease progression of Alzheimer's, highlighting the need for diverse pharmacological targets in treatment.

MOLECULAR NEUROBIOLOGY (2021)

Article Neurosciences

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease

Mohammad Azizur Rahman et al.

Summary: The review highlights the common links between COVID-19 and AD, emphasizing the importance of understanding these shared factors in developing therapeutic strategies, particularly in the urgent need for COVID-19 medication and the cognitive disruptions in AD.

MOLECULAR NEUROBIOLOGY (2021)

Article Medicine, Research & Experimental

The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease

Elisa Avolio et al.

Summary: The study found that the S protein of SARS-CoV-2 may lead to dysfunction and death of pericytes, potentially contributing to microvascular injury, and it activates the ERK1/2 pathway through the CD147 receptor, which could play a role in microvascular damage.

CLINICAL SCIENCE (2021)

Article Multidisciplinary Sciences

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Bryan A. Johnson et al.

Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.

NATURE (2021)

Letter Medicine, General & Internal

Microvascular Injury in the Brains of Patients with Covid-19

Daniel P. Perl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Neurosciences

Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID

Erin Clough et al.

Summary: Clinical data from the COVID-19 pandemic shows that 40% of patients may develop neurological symptoms due to viral encephalitis, while chronic neuro-inflammation in long haulers may lead to Neuro-COVID. Research suggests that SARS-COV2 induces mitochondrial dysfunction and triggers apoptotic pathway in microglial and neuronal cells. Treatment with SARS-COV2 spike protein increases inflammation, oxidative stress, apoptosis, and oxygen consumption rate in microglial cells, leading to cell death. Raman spectroscopy reveals changes in phospholipids composition, providing insights into SARS-COV2 induced mitochondrial dysfunction associated with Neuro-COVID.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Review Neurosciences

COVID-19 and Alzheimer's Disease

Marcello Ciaccio et al.

Summary: SARS-CoV-2 can cause neurological symptoms, potentially affecting the nervous system and increasing the risk of developing neurodegenerative diseases, with a mutualistic relationship found with Alzheimer's Disease.

BRAIN SCIENCES (2021)

Article Pathology

Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein *

Gerard J. Nuovo et al.

Summary: Neurologic complications of symptomatic COVID-19 are commonly seen, with brain tissues from autopsies showing the presence of pseudovirions in endothelial cells. The spike protein was found to induce ACE2+ endothelial damage, highlighting its central role in SARS-CoV2 pathology. Immunohistochemistry for caspase-3 and ACE2 can be used by diagnostic pathologists to document endothelial cell damage in COVID-19.

ANNALS OF DIAGNOSTIC PATHOLOGY (2021)

Article Anatomy & Morphology

A Standardization Protocol for the In Situ Detection of SARS-CoV2 RNA and Proteins

Gerard J. Nuovo et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system

Michal Herman-Edelstein et al.

Summary: This study found that ACE2 expression is increased in diabetic hearts and positively correlated with glycosylated hemoglobin, body mass index, and activation of the renin angiotensin system, indicating that patients with uncontrolled diabetes or obesity with RAS activation have higher ACE2 expression and are at higher risk for severe infection. Additionally, there was no correlation between plasma free ACE2 and cardiac tissue ACE2 expression. Transmembrane serine protease 2, metalloprotease ADAM10, and ADAM17, which facilitate viral-ACE2 complex entry and degradation, were increased in diabetic hearts.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Multidisciplinary Sciences

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

Toni M. Delorey et al.

Summary: This study using single-cell and spatial atlases revealed the impact of COVID-19 infection on lung, kidney, liver, and heart tissues, showing structural remodeling and viral RNA enrichment. Differences in lung inflammatory responses and transcriptional alterations in heart tissue of COVID-19 patients were also identified, along with cell types and genes associated with disease severity.

NATURE (2021)

Review Neurosciences

COVID-19 and Alzheimer's disease: how one crisis worsens the other

Xiaohuan Xia et al.

Summary: There is a bidirectional relationship between COVID-19 and AD. Individuals with AD are at higher risk of contracting COVID-19, while COVID-19 can also potentially lead to cognitive impairment and progression to AD. Additionally, the COVID-19 crisis worsens symptoms in uninfected AD patients and poses new challenges for dementia prevention.

TRANSLATIONAL NEURODEGENERATION (2021)

Article Neurosciences

INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia

Andy P. Tsai et al.

Summary: Alzheimer's disease (AD) is a progressive neurodegenerative disorder with microglia playing a prominent role in late-onset AD. Studies have shown that inositol polyphosphate-5-phosphatase (INPP5D) is selectively expressed in brain microglia and its increased expression may be a risk factor in AD. INPP5D expression increases as the disease progresses, particularly in plaque-associated microglia, suggesting INPP5D as a potential therapeutic target for AD.

NEUROBIOLOGY OF DISEASE (2021)

Article Biochemistry & Molecular Biology

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice

Zhenfei Bi et al.

Summary: The study established a mouse model for SARS-CoV-2-induced ARDS in a standard laboratory setting, capturing multiple characteristics of ARDS observed in humans. Therapeutic strategies such as dexamethasone or passive antibody therapy were shown to effectively ameliorate the disease progression in this model. This model may serve as a robust tool for researchers to investigate the pathological mechanisms and develop new therapeutic strategies for COVID-19 and ARDS.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Biochemistry & Molecular Biology

Small molecule targeting of SHIP1 and SHIP2

William G. Kerr et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2020)

Article Biochemistry & Molecular Biology

Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer's Disease

Maria Sanchez-Campillo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Geriatrics & Gerontology

Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias

Eric E. Brown et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)

Letter Medicine, General & Internal

Neurologic Features in Severe SARS-CoV-2 Infection

Julie Helms et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Clinical Neurology

Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality

Hanin A. AboTaleb

CURRENT NEUROVASCULAR RESEARCH (2020)

Editorial Material Neurosciences

Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies

Sean X. Naughton et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Pathology

Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx

Gerard J. Nuovo et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2020)

Article Endocrinology & Metabolism

COVID-19 and Diabetes: A Collision and Collusion of Two Diseases

Eva L. Feldman et al.

DIABETES (2020)

Article Neurosciences

Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia

Jordi A. Matias-Guiu et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Review Medicine, General & Internal

Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection

Rafal Szelenberger et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Immunology

Impact of Diabetes in Patients Diagnosed With COVID-19

Mohamed Abu-Farha et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Neurosciences

The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease

Mahdi Montazer Haghighi et al.

NEUROSCIENCE INSIGHTS (2020)

Article Immunology

Glial activation and inflammation along the Alzheimer's disease continuum

Kaja Nordengen et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Article Immunology

MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology

Javier H. Jara et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Article Neurosciences

Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study

Diana K. Franco-Bocanegra et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Article Pathology

microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia

Esmerina Tili et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2018)

Review Neurosciences

Role of Glutamate and NMDA Receptors in Alzheimer's Disease

Rui Wang et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Anatomy & Morphology

Expression Pattern of the BCL6 and ITM2B Proteins in Normal Human Brains and in Alzheimer Disease

Beverly W. Baron et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)

Article Clinical Neurology

Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease

Peter Maat et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)

Review Biochemistry & Molecular Biology

Molecular bases of immune complex pathology

K. V. Shmagel et al.

BIOCHEMISTRY-MOSCOW (2009)

Review Biochemistry & Molecular Biology

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

MR Hynd et al.

NEUROCHEMISTRY INTERNATIONAL (2004)

Article Clinical Neurology

βAPP and furin mRNA concentrates in immature senile plaques in the brain of Alzheimer patients

M Marcinkiewicz

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)